3M-051 (ASN technology conjugated, adjuvant) (3M/Stamford Pharmaceutical)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name3M-051 (ASN technology conjugated, adjuvant) (3M/Stamford Pharmaceutical)
Drug Alias Name3M-051 (ASN technology conjugated, adjuvant) (3M/Ascend)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonistsToll like receptor 8 agonists
TargetsToll like receptor 7Toll like receptor 8
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKindeva Drug Delivery LP
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKindeva Drug Delivery LPStamford Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A